Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nurbek Mambetsariev

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Investigation|July 18, 2023
Differential roles of regulatory T cells in acute respiratory infectionsMilica Jovisic, Nurbek Mambetsariev, Benjamin D Singer, et al.
Scientific Reports|November 21, 2019
Author Correction: TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cellsAmy L Whillock, Nurbek Mambetsariev, Wai W Lin, et al.
Scientific Reports|September 11, 2019
TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cellsAmy L Whillock, Nurbek Mambetsariev, Wai W Lin, et al.
The Journal of Biological Chemistry|July 16, 2014
Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progressionFrances E Lennon, Tamara Mirzapoiazova, Nurbek Mambetsariev, et al.
Scientific Reports|October 19, 2016
TRAF3 deficiency promotes metabolic reprogramming in B cellsNurbek Mambetsariev, Wai W Lin, Alicia M Wallis, et al.
Blood Advances|January 4, 2018
The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiencyPradeep Bangalore-Prakash, Laura L Stunz, Nurbek Mambetsariev, et al.
Frontiers in Oncology|August 11, 2015
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer ProgressionTamara Mirzapoiazova, Nurbek Mambetsariev, Frances E Lennon, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2016
Nuclear TRAF3 is a negative regulator of CREB in B cellsNurbek Mambetsariev, Wai W Lin, Laura L Stunz, et al.
The Journal of Biological Chemistry|October 17, 2009
Dynamin 2 and c-Abl are novel regulators of hyperoxia-mediated NADPH oxidase activation and reactive oxygen species production in caveolin-enriched microdomains of the endotheliumPatrick A Singleton, Srikanth Pendyala, Irina A Gorshkova, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 2010
Hyaluronic Acid binding protein 2 is a novel regulator of vascular integrityNurbek Mambetsariev, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Investigation|July 18, 2023
Differential roles of regulatory T cells in acute respiratory infectionsMilica Jovisic, Nurbek Mambetsariev, Benjamin D Singer, et al.
Scientific Reports|November 21, 2019
Author Correction: TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cellsAmy L Whillock, Nurbek Mambetsariev, Wai W Lin, et al.
Scientific Reports|September 11, 2019
TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cellsAmy L Whillock, Nurbek Mambetsariev, Wai W Lin, et al.
The Journal of Biological Chemistry|July 16, 2014
Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progressionFrances E Lennon, Tamara Mirzapoiazova, Nurbek Mambetsariev, et al.
Scientific Reports|October 19, 2016
TRAF3 deficiency promotes metabolic reprogramming in B cellsNurbek Mambetsariev, Wai W Lin, Alicia M Wallis, et al.
Blood Advances|January 4, 2018
The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiencyPradeep Bangalore-Prakash, Laura L Stunz, Nurbek Mambetsariev, et al.
Frontiers in Oncology|August 11, 2015
HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer ProgressionTamara Mirzapoiazova, Nurbek Mambetsariev, Frances E Lennon, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2016
Nuclear TRAF3 is a negative regulator of CREB in B cellsNurbek Mambetsariev, Wai W Lin, Laura L Stunz, et al.
The Journal of Biological Chemistry|October 17, 2009
Dynamin 2 and c-Abl are novel regulators of hyperoxia-mediated NADPH oxidase activation and reactive oxygen species production in caveolin-enriched microdomains of the endotheliumPatrick A Singleton, Srikanth Pendyala, Irina A Gorshkova, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 1, 2010
Hyaluronic Acid binding protein 2 is a novel regulator of vascular integrityNurbek Mambetsariev, Tamara Mirzapoiazova, Bolot Mambetsariev, et al.
Pageof 2